Advances in chemotherapy for renal cell carcinoma.
Huben
R P
RP
Department of Urologic Oncology, Roswell Park Cancer Institute, Buffalo, NY 14263.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D002940:Circadian Rhythm; D004334:Drug Administration Schedule; D004351:Drug Resistance; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents